Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 03, 2015 7:58 PM ET

Healthcare Equipment and Supplies

Company Overview of NeoChord, Inc.

Company Overview

NeoChord, Inc., a medical device company, focuses on minimally invasive mitral valve repair solutions. It develops a proprietary device that allows mitral valve repair to be performed on a beating heart through a two to three inch incision between the ribs in patients with severe, degenerative mitral valve regurgitation. The company offers NeoChord DS1000, a disposable device that is intended to replace damaged chordae by delivering artifical chordae tendinae or "neochords" in a beating heart. It primarily serves customers in Europe. The company was founded in 2007 and is based in Eden Prairie, Minnesota.

7700 Equitable Drive

Suite 206

Eden Prairie, MN 55344

United States

Founded in 2007

Phone:

952-698-7800

Fax:

952-467-6077

Key Executives for NeoChord, Inc.

Chief Executive Officer and President
Age: 48
Contract Chief Financial Officer
Vice President of Research and Development
Director of Quality
Professional Advisor
Compensation as of Fiscal Year 2015.

NeoChord, Inc. Key Developments

Neochord, Inc. Announces Management Changes

NeoChord, Inc. announced appointment of David H. Chung as President and CEO, effective immediately, replacing John Seaberg, who resigned. NeoChord also announced that Michael Fulton has been elected as Chairman of the Board. Most recently, David Chung served as Chief Commercial Officer at AcelRx Pharmaceuticals, Inc. Michael Fulton is a Managing Director at Hopen Life Science Ventures, has over twenty years of experience in the life sciences.

NeoChord Inc. Closes $3 Million Credit Facility with Square 1 Bank

NeoChord Inc. announced that on September 9, 2013, the company closed on a $3 million credit facility with Square 1 Bank.

Similar Private Companies By Industry

Company Name Region
Oceanic Medical Products, Inc. United States
The Tech Group, Inc. United States
Links Medical Products, Inc. United States
MedGyn Products Inc. United States
Soleus Mobility, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
May 11, 2015
--
Private Placement
February 2, 2015
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NeoChord, Inc., please visit www.neochord.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.